The endocannabinoid system as an emerging target of pharmacotherapy

P Pacher, S Bátkai, G Kunos - Pharmacological reviews, 2006 - ASPET
The recent identification of cannabinoid receptors and their endogenous lipid ligands has
triggered an exponential growth of studies exploring the endocannabinoid system and its …

The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina

JP SanGiovanni, EY Chew - Progress in retinal and eye research, 2005 - Elsevier
In this work we advance the hypothesis that omega-3 (ω-3) long-chain polyunsaturated fatty
acids (LCPUFAs) exhibit cytoprotective and cytotherapeutic actions contributing to a number …

Distribution of the endocannabinoid system in the central nervous system

SSJ Hu, K Mackie - Endocannabinoids, 2015 - Springer
The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids),
the enzymes that synthesize and degrade endocannabinoids, and the receptors that …

Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives

AC Burggren, A Shirazi, N Ginder… - The American journal of …, 2019 - Taylor & Francis
Background: Cannabis is the most widely used illicit substance worldwide, and legalization
for recreational and medical purposes has substantially increased its availability and use in …

Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown

PH Reggio - Current medicinal chemistry, 2010 - ingentaconnect.com
The cannabinoid CB1 and CB2 receptors are Class AG protein-coupled receptors (GPCRs).
While many Class A GPCRs have endogenous ligands that are hydrophilic cations (eg, the …

Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin

S Ständer, M Schmelz, D Metze, T Luger… - Journal of dermatological …, 2005 - Elsevier
BACKGROUND:: Cannabinoid receptors mediate the psychopharmacological action of
marijuana and have been localized in the central and peripheral nervous system as well as …

Therapeutic potential of cannabinoids in CNS disease

JL Croxford - CNS drugs, 2003 - Springer
The major psychoactive constituent of Cannabis sativa, Δ 9-tetrahydrocannabinol (Δ 9-THC),
and endogenous cannabinoid ligands, such as anandamide, signal through G-protein …

The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation

D Thapa, EA Cairns, AM Szczesniak… - Cannabis and …, 2018 - liebertpub.com
Abstract Background and Purpose: Corneal injury can result in dysfunction of corneal
nociceptive signaling and corneal sensitization. Activation of the endocannabinoid system …

The endocannabinoid nervous system: unique opportunities for therapeutic intervention

AC Porter, CC Felder - Pharmacology & therapeutics, 2001 - Elsevier
The active principle in marijuana, Δ9-tetrahydrocannabinol (THC), has been shown to have
wide therapeutic application for a number of important medical conditions, including pain …

A review of systemic medications that may modulate the risk of glaucoma

A Wu, AP Khawaja, LR Pasquale, JD Stein - Eye, 2020 - nature.com
With increasing longevity, patients are developing more and more chronic diseases that
require treatment with medications. Yet, it is not fully understood the extent by which these …